Literature DB >> 34756653

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Martha Gulati, Phillip D Levy, Debabrata Mukherjee, Ezra Amsterdam, Deepak L Bhatt, Kim K Birtcher, Ron Blankstein, Jack Boyd, Renee P Bullock-Palmer, Theresa Conejo, Deborah B Diercks, Federico Gentile, John P Greenwood, Erik P Hess, Steven M Hollenberg, Wael A Jaber, Hani Jneid, José A Joglar, David A Morrow, Robert E O'Connor, Michael A Ross, Leslee J Shaw.   

Abstract

AIM: This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.
METHODS: A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing randomized and nonrandomized trials, observational studies, registries, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered. STRUCTURE: Chest pain is a frequent cause for emergency department visits in the United States. The "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain" provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. This guideline presents an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated, and shared decision-making with patients is recommended.
Copyright © 2021 by the American Heart Association, Inc., and the American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACC/AHA Clinical Practice Guidelines; accelerated diagnostic pathway; acute coronary syndrome; angina; biomarkers; cardiac imaging; chest pain; chest pain syndromes; clinical decision pathway; coronary artery disease; myocardial infarction; myocardial injury; myocardial ischemia; noncardiac; noncardiac chest pain; sex differences; shared decision-making; troponins

Mesh:

Year:  2021        PMID: 34756653     DOI: 10.1016/j.jacc.2021.07.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

Review 1.  [The AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines 2021 on thoracic pain].

Authors:  Bernhard Maisch
Journal:  Herz       Date:  2022-01-03       Impact factor: 1.443

2.  ASNC's thoughts on the AHA/ACC chest pain guidelines.

Authors:  Randall C Thompson; Mouaz H Al-Mallah; Rob S B Beanlands; Dennis A Calnon; Sharmila Dorbala; Lawrence M Phillips; Donna M Polk; Prem Soman
Journal:  J Nucl Cardiol       Date:  2021-11-15       Impact factor: 5.952

Review 3.  [Computed tomography and magnetic resonance imaging in cardiac diagnostics-how to choose the right modality : A guide based on the new guidelines of the European Society of Cardiology (ESC)].

Authors:  Robin F Gohmann; Malte M Sieren; Matthias Gutberlet
Journal:  Radiologie (Heidelb)       Date:  2022-10-12

Review 4.  Machine learning applications in cardiac computed tomography: a composite systematic review.

Authors:  Jonathan James Hyett Bray; Moghees Ahmad Hanif; Mohammad Alradhawi; Jacob Ibbetson; Surinder Singh Dosanjh; Sabrina Lucy Smith; Mahmood Ahmad; Dominic Pimenta
Journal:  Eur Heart J Open       Date:  2022-03-17

5.  2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Ty J Gluckman; Nicole M Bhave; Larry A Allen; Eugene H Chung; Erica S Spatz; Enrico Ammirati; Aaron L Baggish; Biykem Bozkurt; William K Cornwell; Kimberly G Harmon; Jonathan H Kim; Anuradha Lala; Benjamin D Levine; Matthew W Martinez; Oyere Onuma; Dermot Phelan; Valentina O Puntmann; Saurabh Rajpal; Pam R Taub; Amanda K Verma
Journal:  J Am Coll Cardiol       Date:  2022-03-16       Impact factor: 27.203

6.  Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial.

Authors:  Márton Kolossváry; Thomas Mayrhofer; Maros Ferencik; Júlia Karády; Neha J Pagidipati; Svati H Shah; Michael G Nanna; Borek Foldyna; Pamela S Douglas; Udo Hoffmann; Michael T Lu
Journal:  J Cardiovasc Comput Tomogr       Date:  2022-03-26

7.  State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?

Authors:  Ramya C Mosarla; Ehrin Armstrong; Yonatan Bitton-Faiwiszewski; Peter A Schneider; Eric A Secemsky
Journal:  J Soc Cardiovasc Angiogr Interv       Date:  2022-08-20

8.  Limitations of Observational Studies for Aspirin in Primary Prevention and the Need for Randomized Trials.

Authors:  Arzu Canan; Ann Marie Navar
Journal:  Radiol Cardiothorac Imaging       Date:  2022-04-28

Review 9.  Stress electrocardiography testing in coronary artery disease: Is it time for its swan song or to redefine its role in the modern era ?

Authors:  Gnanasundaram Ananthasubramaniam; Karthikeyan Ananthasubramaniam
Journal:  Indian Heart J       Date:  2022-02-12

Review 10.  Cardiovascular Imaging for Ischemic Heart Disease in Women: Time for a Paradigm Shift.

Authors:  Patricia F Rodriguez Lozano; Elona Rrapo Kaso; Jamieson M Bourque; Mohamed Morsy; Angela M Taylor; Todd C Villines; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2022-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.